Billionaire Stanley Druckenmiller Dumped Duquesne's Entire Stake in Broadcom and Bought One of Wall Street's Hottest Drug Stocks Hand Over Fist
Duquesne Family Office's billionaire chief shed a trillion-dollar artificial intelligence (AI) stock in favor of a historically cheap drugmaker that's more than doubled in less than two years.
Though earnings season -- the roughly six-week period each quarter where a majority of S&P 500 companies reveal their latest operating results -- provides plenty of juicy data for investors to sift through, there's arguably no data release more important than quarterly filed Form 13F filings with the Securities and Exchange Commission.
A 13F offers investors an under-the-hood look at which stocks Wall Street's most-successful asset managers were buying and selling in the latest quarter (in this case, the fourth quarter), and is a required filing for institutional investors with at least $100 million in assets under management (AUM). The deadline to file Form 13F for the fourth quarter was Feb. 14.
Even though 13F data can be more than six-weeks old when filed, it clues investors into which stocks, industries, sectors, and next-big-thing trends have the full and undivided attention of Wall Street's top money managers.
